AMDS Clearing House Dr Jos Perriens Coordinator TCO Unit/HIV, WHO.

Slides:



Advertisements
Similar presentations
Price Reporting Mechanism (PRM): Lessons learnt and how to use the evidence from the PRM Technical Briefing Seminar for Consultants on Procurement and.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
National PSM Coordination Mechanism Dr Vincent Habiyambere WHO/HIV Department AIDS Medicines & Diagnostics Service (AMDS) Bangkok, July 2005.
AMDS Contribution to the Technical Briefing Seminar October 2007.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
Improving the quality of data in the Global Price Reporting Mechanism for a reliable market intelligence project International Multi-stakeholder Consultation.
World Health Organization
Project Overview 2010 Programme FA: 14 June 2007 Start: 2 Sept 2007 Completion: 31 June 2011 Budget: €10,155,000 (EU), €155,000 (National)
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
USAID Update 2014 Bureau for Global Health Christine Malati, PharmD
Access to HIV/AIDS, Tuberculosis and Malaria Medicines. WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies. Geneva, 18 – 22 September.
UN Prequalification: UNICEF Perspective 5 th UN Prequalification stakeholders meeting 11th February 2009.
Access to ARVs in low and middle income countries - Joseph Perriëns Coordinator HIV technology and commodities HIV dept. World Health Organization.
Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.
Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.
Iman Wanis, Cushla Coffey, Shaffiq Essajee, and Philippa Easterbrook World Health Organization, HIV Department (ATC) Geneva, Switzerland July 2011 COSTING.
UNITAID’s Market Approach in HIV Diagnostics Brenda Waning International AIDS Society 18 July, 2011 Rome.
Quantification in Resource- limited settings Laila Akhlaghi February 28, 2007.
PROCUREMENT SUPPORT SERVICE WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November 1 st -5 th 2010 Mariatou Tala Jallow, Manager,
Agricultural Market Information System (AMIS): State of Play AMIS First Meeting of the Rapid Response Forum 11 April 2012 Mexico City Abdolreza Abbassian,
Monitoring Drug Resistant Tuberculosis Treatment in Brazil through an Innovative Web-based Information System Dr. Luis Gustavo Bastos Management Sciences.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
4 th - 18 November 2011 ICIUM 2011 Conference Antalya, Turkey 16/10/2015.
Approval Mechanism for Suppliers of Malaria Drugs and Nets Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines & Supplies Services.
WHO and the Global Fund harmonized tool for Pharmaceutical Country Profiles Richard Laing & Enrico Cinnella, November 2011.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
WHO-HIV Department Strategic Information Unit AIDS Medicines and Diagnostics Service Contribution to Access to medicines Technical Briefing Seminar, November.
Overview of the Global Fund Procurement and Supply Management Issues Workshop for LAC Consultants th July 2009 Pharmaceutical Management Advisory.
Quality Assurance for pharmaceutical products in international procurement Approach of major donors and procurers Core presentation prepared by Sophie.
TM Emerging Health Threats and Health Information Systems: Getting Public Health and Clinical Medicine to Real Time Response John W. Loonsk, M.D. Associate.
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
Measured Progress ©2011 Guide to the Smarter Balanced IT Architecture Connecticut Assessment Forum August 14, 2012.
AIDS Medicines and Diagnostics Services - a network of organizations supporting access to HIV medicines and diagnostics J. Perriëns.
World Health Organization "3 by 5" Target Treat 3 million by 2005.
1 CLUSTER : Pharmaceutical Policy & Planning Strategic Plans 2004/ /6 2006/7 31 May 2004.
Overview of the AMDS Products
Sub module 1 Introduction to HIV care and ART recording and reporting system.
Indicators for monitoring and assessing pharmaceutical situation in countries Dr. Edelisa D. Carandang Drug Action Program (DAP) Essential Drugs and Medicines.
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? November 2009, dar Es Salaam.
TBS Meeting Geneva, November 2010 Procurement and Supply Management Policies WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, November.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
Dashboard Country Coordinating Mechanism Honduras Tegucigalpa, May 2007.
Monitoring of Pharmaceutical Supply in Countries of Eastern Europe, Central Asia and Caucasus Anna Żakowicz European AIDS Treatment Group Presented at.
Aarkstore - Metastatic Ovarian Cancer- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Category : Pharmaceuticals and Healthcare.
Improving Access for Quality-Assured TB Medicines and Diagnostics Medicines and Diagnostics Improving Access for Quality-Assured TB Medicines and Diagnostics.
IMPROVING ACCESS AND INNOVATION IN HIV THROUGH VOLUNTARY LICENSING: THE EXPERIENCE OF THE MEDICINES PATENT POOL ICASA – Harare, Zimbabwe Session on Innovation.
1 |1 | Quality of Active Pharmaceutical Ingredients Beijing, 31 March 2010 Access to Assured-Quality Praziquantel for the Control of Human Schistosomiasis.
The price trends of HIV/AIDS medicines: Finding and using data Dr. Perriëns Joseph Coordinator SSH Unit, WHO.
WHO Global Price Reporting Mechanism, the importance of data registration for the regulation of antiretrovirals (ARV) and PSM issues related to access.
Global Health Supply Chain Program (GHSC)
Access to Medicines for HIV/AIDS, Tuberculosis and Malaria.
Remodeling a House in Orange County
World Health Organization
World Health Organization
World Health Organization
World Health Organization
No Conflict of Interest
World Health Organization
B. Dongmo Nguimfack AMDS TCO Unit/HIV, WHO
Overview of the AMDS Products
Global Action Plan on HIVDR 2018 Progress Report
AMDS Products, events and issues.
Access to HIV/AIDS Medicines The 3x5 strategy
Guide to Writing The Procurement and Supply Management Plan
WHO Global HIV/AIDS Staff Meeting
The Global Fund to Fight AIDS, Tuberculosis and Malaria
Presentation transcript:

AMDS Clearing House Dr Jos Perriens Coordinator TCO Unit/HIV, WHO

Objectives of the clearing house Collect, consolidate and disseminate strategic information regarding affordability, accessibility, and availability of HIV drugs: data on price and registration In-house Products Global Price Reporting Mechanism - on AMD website Regulatory status database - on AMD website Controlled Medicines (Methadone+buprenorphine+morphine) database - on AMD website API prices - on AMD website Forecasting of global ARV demand - on AMD website PSM Toolbox Clearing house

AMDS Information Platform Global Price Repor- ting Mecha- nism APIAPI Regula- tory status Opioïd Sub- stitution Therapy data- base HTMH HT HTM HH H HTM H Fore- casting portal (surveys, back- ground, papers) Treat- ment guide- lines repo- sitory PQ (EMP) Corpo- rate Pricing Policies (MSF) Capacity building tools: PSM Toolbox

Improvements currently being implemented in the Global Price Reporting Mechanism [GPRM]

Old GPRM

New database with more fields: Done Might be revised to accommodate diagnostics Open pluggable architecture: Done Waiting for the validation and normalization algorithms from ANRS New administrative interface: Done Missing publication interface New download interface: In progress New reporting/visualisation interface: In progress Tool deployed (Inetsoft) Database as decision making tool in the public domain end 2011 New GPRM Status

Visualization interface Future GPRM Dashboards Data MashupsReports Inetsoft Style Intelligence

SOURCES AND PRICES OF ACTIVE PHARMACEUTICAL INGREDIENTS

Forecasting antiretroviral demand

Opioid substitution therapy and morphine database

PROCUREMENT & SUPPLY MANAGEMENT TOOLBOX

URL for the different databases Global Price Reporting Mechanism (GPRM): The Drug Regulatory Status Database: PSM Toolbox website: SOURCES AND PRICES OF ACTIVE PHARMACEUTICAL INGREDIENTS Controlled Medicines: Forecasting antiretroviral demand: Prequalification Project

Contacts Boniface Dongmo Nguimfack –Global Price Reporting Mechanism (GPRM) –The Drug Regulatory Status Database –SOURCES AND PRICES OF ACTIVE PHARMACEUTICAL INGREDIENTS –Controlled Medicines –Summary report from the Global Price Reporting Mechanism Vincent Habiyambere –PSM Toolbox –Forecasting antiretroviral demand –Early warning indicators to prevent stock-out and overstock

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.